Similar articles

• In utero exposure to levetiracetam vs valproate: development and language at 3 years of age.

  Shallcross R, Bromley RL, Cheyne CP, García-Fiñana M, Irwin B, Morrow J, Baker GA; Liverpool and Manchester Neurodevelopment Group; UK Epilepsy and Pregnancy Register. Shallcross R, et al. Neurology. 2014 Jan 21;82(3):213-21. doi: 10.1212/WNL.0000000000000030. Epub 2014 Jan 8. Neurology. 2014. PMID: 24401687
• Fine-tuning risk assessment with antiepileptic drug use in pregnancy.

  Tomson T, Klein P. Tomson T, et al. Neurology. 2015 Jan 27;84(4):339-40. doi: 10.1212/WNL.0000000000001197. Epub 2014 Dec 24. Neurology. 2015. PMID: 25540318 No abstract available.
• Fine-tuning risk assessment with antiepileptic drug use in pregnancy.

  Mawer G, Bromley R, Baker GA, Meador KJ, Clayton-Smith J. Mawer G, et al. Neurology. 2015 Oct 13;85(15):1354. doi: 10.1212/WNL.0000000000002050. Neurology. 2015. PMID: 26459942 Free PMC article. No abstract available.
• Developmental toxicity of antiepileptic drugs: relationship to postnatal dysfunction.

  Fisher JE, Vorhees CV. Fisher JE, et al. Pharmacol Res. 1992 Oct-Nov;26(3):207-21. doi: 10.1016/1043-6618(92)90210-3. Pharmacol Res. 1992. PMID: 1437987 Review. No abstract available.
• Is carbamazepine a human teratogen?

  Vajda FJE, O'Brien TJ, Graham J, Lander CM, Eadie MJ. Vajda FJE, et al. J Clin Neurosci. 2016 Jan;23:34-37. doi: 10.1016/j.jocn.2015.07.011. Epub 2015 Oct 27. J Clin Neurosci. 2016. PMID: 26521756 Review.